A study of 187 patients (201 eyes) with branch retinal-artery occlusion (BRAO) was done to determine the etiology, natural history, and treatment of this disorder. On follow-up, almost 90% of the patients had visual acuity of 20/40 or better. The rest had poor visual acuities initially. The patient population was divided into three groups according to treatment. Group I included 65 patients treated aggressively with mechanical and pharmaceutic measures to reduce intraocular pressure and with anti-platelet drugs. Group II was composed of 81 patients treated only with antiplatelet agents given chronically. Group III (41 patients) received no treatment and represented the control group. No statistically significant difference in visual outcome was found on comparison of these three groups of patients. In this study we observed that 98% of the BRAO cases involved the temporal arteries. Emboli were documented in 125 eyes (62%). Systemic hypertension was common (132 patients or 71%). Although BRAO appears to be a relatively benign disease, its association with severe systemic conditions and documented increase in patient mortality suggests the need for careful evaluation by ophthalmologists.
Download full-text PDF |
Source |
---|
Retin Cases Brief Rep
January 2025
Department of Ophthalmology, American University of Beirut, Beirut, Lebanon.
Purpose: To report a successful case of vision restoration and macular reperfusion following branch retinal artery occlusion (BRAO) using pars plana vitrectomy with undermining the artery off the retinal bed.
Methods: This case report involves a 75-year-old patient who was diagnosed immediately with BRAO following cardiac catheterization procedure. An embolus at the superior retinal artery bifurcation was noted.
Kaohsiung J Med Sci
January 2025
College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Retinal artery occlusion (RAO) is a critical ophthalmic emergency with a high risk of significant visual impairment. While traditional treatment aims to promptly restore blood flow to the retina, recent research has investigated the potential benefits of anticoagulation therapy for managing this condition. This paper reviews current literature and clinical trials investigating the efficacy and safety of anticoagulant and antiplatelet therapies, such as systemic heparinization and direct oral anticoagulants and aspirin, in treating RAO.
View Article and Find Full Text PDFJ Clin Med
December 2024
Department of Ophthalmology, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.
: Central and branch retinal artery occlusion (CRAO and BRAO) are critical causes of acute vision loss, predominantly affecting older adults with systemic vascular pathology. These occlusions typically result from embolic events, leading to partial or complete retinal ischemia. : This retrospective case series report details of our 10-year experience using the 1064 nm Nd:YAG laser for Transluminal Nd:YAG Embolysis (TYE) in order to lyse visible emboli within the retinal arteries.
View Article and Find Full Text PDFSusac is a rare systemic disease characterized by ischemic events involving the cochlea, brain, and retina. Delay in the diagnosis leads to sight-threatening complications such as neovascular glaucoma.
View Article and Find Full Text PDFCureus
November 2024
Neurology, King's College Hospital, Dubai, ARE.
Susac's syndrome is a rare inflammatory microangiopathy characterized by the triad of retinopathy, encephalopathy, and hearing loss. The syndrome causes recurrent microinfarcts in these organs, which in turn manifests with repeated attacks of visual field loss, hearing loss and tinnitus, and various brain syndromes. These often lead to the significant accumulation of disability over time, particularly if there is a delay or failure in diagnosis.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!